• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • End of Year Giving
  • Join PeDRA
  • Login
MENUMENU
  • Contact
  • Events
  • For Researchers
        • Grants & Awards
        • PeDRA Studies
        • Resources For Researchers
        • Education for Researchers
        • Early Career Support
        • Publications
        • Clinical Trials
        • Thank you to everyone who applied for a Research Grant, Consensus Grant, or Weston Career Development Award in December 2019.  Please keep an eye out for more funding opportunities from PeDRA in 2020.

  • For Patients & Families
        • Support
        • Education for Patients & Families
        • Engagement Award

           

          PeDRA has been selected for Engagement Award funding from PCORI to develop a skilled community of stakeholders committed to driving patient-centered research that improves the lives of children with skin diseases and their families.

  • Research Areas
        • Birthmarks
        • Genetic Skin Disorders
        • Inflammatory Skin Disease
        • Neonatal Skin
        • Skin Tumors and Reactions to Cancer Therapies (STARC)
        • Cross-Cutting Research
        • PeDRA Studies

           

          Applications being accepted for new and ongoing studies and surveys to receive special benefits as “PeDRA Studies.”

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports
        • Patient Partners
        • Our Supporters
        • PeDRA is an independent nonprofit organization that serves as the research arm of the Society for Pediatric Dermatology.

Melanoma and nonmelanoma skin cancer in children and young adults

November 10, 2019 By Mike Siegel

Co-Principal Investigators:

Jen Huang, MD – Harvard Medical School and Larry Eichenfield, MD – UCSD

Overview:

This study is a collaboration of 10 major hospitals across the country with the unified goal of improving our understanding of skin cancer in children.  It is a multi-center retrospective case controlled study of all children < 20 years of age with the diagnosis of melanoma or nonmelanoma skin cancer (NMSC) over a 20 year period from 1995 to 2015.  We aimed to characterize the clinical and histopathologic features of melanoma and NMSC in children and to identify risk factors associated with development of these skin cancers, including exposure to chemotherapeutic agents, radiation therapy, immunosuppressive medications, and photosensitizing agents. 

The major goal of the study is to understand what risk factors are associated with development of melanoma and NMSC in children and young adults.  There have been no prior studies addressing this question.  By achieving our study goal, we hope to improve guidelines for skin cancer screening for children.

Status:

One publication in print – Huang, et al., 2019; (see publications page). Analysis is underway for additional publications.

Filed Under: Active Studies, Skin Tumors and Reactions to Cancer Therapies

Reader Interactions

Footer

  • Join PeDRA
  • For Patients
  • For Researchers
  • Forum
  • Facebook
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2019 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy